Kim Cheema

1.1k total citations
13 papers, 172 citations indexed

About

Kim Cheema is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Kim Cheema has authored 13 papers receiving a total of 172 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Nephrology. Recurrent topics in Kim Cheema's work include Vasculitis and related conditions (4 papers), Systemic Lupus Erythematosus Research (4 papers) and Otitis Media and Relapsing Polychondritis (3 papers). Kim Cheema is often cited by papers focused on Vasculitis and related conditions (4 papers), Systemic Lupus Erythematosus Research (4 papers) and Otitis Media and Relapsing Polychondritis (3 papers). Kim Cheema collaborates with scholars based in Canada, United Kingdom and Greece. Kim Cheema's co-authors include David Jayne, Myrto Kostopoulou, George Βertsias, Antonis Fanouriakis, Dimitrios T. Boumpas, Samuel Quan, Kelly B. Zarnke, Robert Quinn, Lawrence de Koning and Neesh Pannu and has published in prestigious journals such as Annals of the Rheumatic Diseases, Nephrology Dialysis Transplantation and Lara D. Veeken.

In The Last Decade

Kim Cheema

8 papers receiving 168 citations

Peers

Kim Cheema
R. Jordana Spain
Pépé Mfutu Ekulu Democratic Republic of the Congo
David Massicotte‐Azarniouch Canada
María Dolores Albaladejo-Otón Spain
Marina Rull‐Gabayet Mexico
Angelito Yango United States
Tracey Hopkins United Kingdom
Indu Ramachandra Rao India
Dini Hui Canada
Anne Elisabeth Heng France
R. Jordana Spain
Kim Cheema
Citations per year, relative to Kim Cheema Kim Cheema (= 1×) peers R. Jordana

Countries citing papers authored by Kim Cheema

Since Specialization
Citations

This map shows the geographic impact of Kim Cheema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Cheema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Cheema more than expected).

Fields of papers citing papers by Kim Cheema

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Cheema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Cheema. The network helps show where Kim Cheema may publish in the future.

Co-authorship network of co-authors of Kim Cheema

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Cheema. A scholar is included among the top collaborators of Kim Cheema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Cheema. Kim Cheema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lee, Holly, Kim Cheema, Peter Duggan, et al.. (2025). Clinical and Pathological Characteristics of Non-AL Amyloidosis MGRS: A Single-Center Experience Over 10 Years. Canadian Journal of Kidney Health and Disease. 12. 1055274030–1055274030.
2.
Cheema, Kim, Daniel A. Muruve, Yvan St. Pierre, et al.. (2025). NOVEL URINARY BIOMARKER MODEL FOR DIFFERENTIATING LUPUS NEPHRITIS FROM ANCA-ASSOCIATED VASCULITIS. The Journal of Rheumatology. 52(Suppl 1). 151.2–152.
3.
Elliott, Susan J., et al.. (2024). Using photovoice to investigate patient experiences of lupus nephritis in Canada. Lupus Science & Medicine. 11(2). e001265–e001265.
4.
Barr, Bryce, Kim Cheema, Aurore Fifi‐Mah, Stephanie Garner, & Louis Girard. (2024). Use of Avacopan in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Estimated Glomerular Filtration Rate <15 ml/min per 1.73 m2. Kidney International Reports. 9(4). 1115–1118. 6 indexed citations
5.
Elliott, Susan J., et al.. (2023). Canadian patient experiences of lupus nephritis: a qualitative analysis. Lupus Science & Medicine. 10(2). e000982–e000982. 3 indexed citations
6.
Mescia, Federica, Allyson Egan, Kim Cheema, Pasupathy Sivasothy, & David Jayne. (2021). Eosinophilic granulomatosis with polyangiitis present and future. Lara D. Veeken. 60(Supplement_3). iii24–iii27.
7.
Elliott, Mark, et al.. (2021). Mainstreaming Genetic Testing for Adult Patients With Autosomal Dominant Polycystic Kidney Disease. Canadian Journal of Kidney Health and Disease. 8. 1015010201–1015010201. 13 indexed citations
8.
Cheema, Kim, Amanda J. Cox, Alasdair Coles, et al.. (2021). Deciphering neurological symptoms in ANCA-associated vasculitis, uncontrolled disease or a complication of therapy. Lara D. Veeken. 60(Supplement_3). iii67–iii69.
9.
10.
11.
Rodrigues, Jennifer C., David Collister, Amy M. Archer, et al.. (2017). P1_185 The Steroid Tapering in ANCA Vasculitis Evaluation Study (STAVE) 2: a Systematic Review and Meta-Analysis. Lara D. Veeken. 56(suppl_3). iii103–iii103. 4 indexed citations
12.
Wilson, Todd, Samuel Quan, Kim Cheema, et al.. (2015). Risk prediction models for acute kidney injury following major noncardiac surgery: systematic review. Nephrology Dialysis Transplantation. 31(2). 231–240. 59 indexed citations
13.
Madsen, Jan, Kevin Fenton, Kevin Stewart, et al.. (2014). Learning from the design and development of the NHS Safety Thermometer. International Journal for Quality in Health Care. 26(3). 287–297. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Jordana Breakdown of academic impact, for papers by Pépé Mfutu Ekulu Breakdown of academic impact, for papers by David Massicotte‐Azarniouch Breakdown of academic impact, for papers by María Dolores Albaladejo-Otón Breakdown of academic impact, for papers by Marina Rull‐Gabayet Breakdown of academic impact, for papers by Angelito Yango Breakdown of academic impact, for papers by Tracey Hopkins Breakdown of academic impact, for papers by Indu Ramachandra Rao Breakdown of academic impact, for papers by Dini Hui Breakdown of academic impact, for papers by Anne Elisabeth Heng
Rankless by CCL
2026